Publications
20
Citations
138
Est. group size
~1
Recurring co-author estimate
Active years
30
Publishing since 1996
Shreya Kumar's research focuses on developing immunotherapy strategies for prostate cancer, particularly using the cytokine IL-27 in combination with chemotherapy and gene therapy approaches to reprogram the tumor microenvironment (the mix of cells and signals surrounding a tumor). This work spans laboratory studies in mouse models, engineering of therapeutic proteins and delivery systems, and analysis of tumor gene activity (transcriptomics) to identify treatment targets.
Publication output has been modest but fairly steady over the last decade, with a slight increase in activity since 2021 averaging under two papers per year.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Exploring tumor dynamics and responses of prostate cancer to IL-27 based treatment combinations through biodynamic imaging and RNA sequencing analyses
Scientific Reports · 2025
- Transcriptomic analysis of mouse TRAMP cell lines and tumors provide insights into shared pathways and therapeutic targets
Cell Insight · 2024
- Reengineering ethics education for deeper student engagement through the creation of roleplaying and decision-making games [WIP Paper, Student Experiences]
2024
- Vinit Sheshnath Vedpathak
BMJ · 2024
- Poly I:C-priming of adipose-derived mesenchymal stromal cells promotes a pro-tumorigenic phenotype in an immunocompetent mouse model of prostate cancer
Frontiers in Cell and Developmental Biology · 2023
- Designing Synthetic Polymers for Nucleic Acid Complexation and Delivery: From Polyplexes to Micelleplexes to Triggered Degradation
Biomacromolecules · 2022
- A Second-Generation Nanoluc-IL27 Fusion Cytokine for Targeted-Gene-Therapy Applications
Bioengineering · 2022
- Reengineering Tumor Microenvironment with Sequential Interleukin Delivery
Bioengineering · 2021
- Instagram Forensic Analysis Revisited: Does anything really vanish?
2021
- 556 Chemo-immunotherapy to treat bone-metastatic prostate cancer
Regular and Young Investigator Award Abstracts · 2021
- Immunogenic Modulation of Prostate Cancer to Enhance IL‐27 Immunotherapy Efficacy
The FASEB Journal · 2020
- Sensitizing Prostate Cancer Cells to IL‐27 Immunotherapy by Chemotherapy Induced Immunogenic Modulation
The FASEB Journal · 2019
- Rapid, label-free CD4 testing using a smartphone compatible device
Lab on a Chip · 2017
- 87 Mesothelin-targeted immunotherapy CRS-207 plus chemotherapy as treatment for malignant pleural mesothelioma (MPM)
Lung Cancer · 2016
- An interesting case of hypoxia.
Journal of the Association of Physicians of India · 2016
- Bioengineering×3
- The FASEB Journal×2
- Lab on a Chip×1
- Biomacromolecules×1
- Frontiers in Molecular Biosciences×1
- Jonathan E. Schoenhals
Medicine · The Ohio State University
- Lei Chen
Medicine · The Ohio State University
- Andrew J. Gunderson
Medicine · The Ohio State University
- Scott A. Hammond
Medicine · The Ohio State University
- Vijaya Bharti
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile